DO comments on bipolar disorder supplement.
Scheinthal
Stephen M
SM
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D000077152:Olanzapine; D014481:United States; D014486:United States Food and Drug Administration
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine